CAH Cardinal Health
- Official Name: CARDINAL HEALTH, INC.
- Headquarters: 7000 Cardinal Pl, DUBLIN, OH, 43017 US
- CEO: Jason M. Hollar
- Website: cardinalhealth.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-14 | 1 | Lost by 2.477 | (2.937) - (0.460) | ||
| 2025-07-21 | 2 | Won by 1.907 | (1.865) - (3.772) | ||
| 2025-07-28 | 3 | Lost by 5.007 | (2.769) - 2.238 | ||
| 2025-07-29 | 2R | Lost by 0.490 | 1.678 - 2.168 | ||
| 2025-08-04 | 4 | Won by 5.111 | 4.034 - (1.077) | ||
| 2025-08-06 | 1R | Lost by 0.454 | (1.334) - (0.880) | ||
| 2025-08-07 | 1R | Lost by 6.121 | (2.113) - 4.008 | ||
| 2025-08-11 | 5 | Lost by 4.647 | (1.651) - 2.996 | ||
| 2025-08-18 | 6 | Lost by 2.028 | 1.501 - 3.529 | ||
| 2025-08-25 | 7 | Won by 0.523 | (0.012) - (0.535) | ||
| 2025-09-01 | 8 | Won by 3.145 | 1.799 - (1.346) | ||
| 2025-09-08 | 9 | Won by 1.569 | 0.982 - (0.587) | ||
| 2025-09-15 | 10 | Lost by 0.686 | (0.006) - 0.680 | ||
| 2025-09-22 | 11 | Won by 2.998 | (2.058) - (5.056) | ||
| 2025-09-29 | 12 | Won by 9.267 | 4.678 - (4.589) | ||
| 2025-10-06 | 13 | Won by 0.135 | 0.352 - 0.217 | ||
| 2025-10-13 | 14 | Lost by 4.966 | (0.593) - 4.373 | ||
| 2025-10-20 | 15 | Won by 0.789 | 1.909 - 1.120 |
Latest News
UBS Maintains Buy on Cardinal Health, Raises Price Target to $295
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $295.

Cardinal Health (CAH) Laps the Stock Market: Here's Why
Cardinal Health (CAH) closed at $253.71 in the latest trading session, marking a +2.41% move from the prior day.

Gilead and Cardinal Health Stocks Jump to Record Highs. Why Healthcare Is on a Tear.
AbbVie, meanwhile, closed just shy of a record high, with shares ticking up 0.6% to $283.40.

3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensi...

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie is raising its outlook with Skyrizi and Rinvoq offsetting Humira losses. Pfizer is rebuilding its pipeline around obesity drugs and key readout...

Level AI's CX Advisory Board adds Shane Abeyratne, SVP at Cardinal Health
Level AI, the customer intelligence platform for contact centers, today announced that Shane Abeyratne, Senior Vice President, Global Business & F...

What to Expect From Cardinal Health’s Q1 2027 Earnings Report
Cardinal Health is set to report its Q1 results next month, with analysts expecting double-digit year-over-year EPS growth.

10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transac...

Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...

Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.

AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie trades at a 40% valuation discount but faces revenue concentration risk, while Eli Lilly's cardiometabolic dominance commands a premium.